Futurepharma Strengthens South Africa's Capacity To Develop And Manufacture Essential Medicines
(MENAFN - APO Group) The launch of the Council for Scientific and Industrial Research's (CSIR) FuturePHARMA facility in Pretoria strengthens South Africa's capacity to develop and manufacture ...
Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.
Read full story on publisher site →